Urinary neurotransmitter testing: Considerations of spot baseline norepinephrine and epinephrine

Open Access Journal of Urology

Volumn 3, Issue 1, 2011, Pages 19-24

  Hinz, Marty ^a   Stein, Alvin ^b   Uncini, Thomas ^c  

^a NeuroResearch Clinics Inc   (United States)

^b Stein Orthopedic Associates   (United States)

^c DBS Labs   (United States)

Author keywords

Dopamine; Epinephrine; Neurotransmitter testing; Norepinephrine; Serotonin

Indexed keywords

ADRENALIN; BIOLOGICAL MARKER; DOPAMINE; NORADRENALIN; SEROTONIN;

ADRENALIN URINE LEVEL; ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOPAMINE URINE LEVEL; FEMALE; HUMAN; LABORATORY TEST; MALE; MEDICAL DECISION MAKING; NORADRENALIN URINE LEVEL; REPRODUCIBILITY; STATISTICAL ANALYSIS; STUDENT T TEST; URINALYSIS;

EID: 79952940164     PISSN: None     EISSN: 11791551     Source Type: Journal    
DOI: 10.2147/OAJU.S16637     Document Type: Article

References (14)

1. Hinz M, Stein A, Trachte G, Uncini T. Neurotransmitter testing of the urine, a comprehensive analysis. Open Access Journal of Urology. 2010;2:177-183.
2. Smythe G, Edwards G, Graham P, Lazarus L. Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine. Clin Chem. 1992;38: 486-492.
3. Hinz M, Stein A, Uncini T. The dual-gate lumen model of renal monoamine transport. Neuropsychiatr Dis Treat. 2010;6:387-392.
4. Hinz M. Depression. In: Kohlstadt I, editor. Food and Nutrients in Disease Management. Boca Raton, FL: CRC Press; 2009.
5. Hinz M, Stein A, Uncini T. Amino acid responsive Crohn's disease. Clinical and Experimental Gastroenterology. 2010;3:171-177.
6. Alts J, Alts D, Bull M. Urinary Neurotransmitter Testing: Myths and Misconceptions. Osceola, WI: NeuroScience Inc; 2007.
7. Watkins R. Validity of urinary neurotransmitter testing with clinical applications of CSM (Communication System Management) model. Asheville, NC: Sanesco International; 2009. Available at: http://www.neurolaboratory.net/lab/neurolab%20pdf.%20 files/2009%20Urinary%20NT%20White%20Paper.pdf. Accessed November 24, 2010.
8. Theirl S. Clinical relevance of neurotransmitter testing. The Original Internist. December 2009. Available at: http://www.clintpublication. com/documents/Dec_OI_2009.pdf. Accessed November 24, 2010.
9. Sanesco. Neurolab baseline sample report. Available at: http://sanesco. net/images/files/resourcelibrary/baseline_sample_report.pdf. Accessed November 24, 2010.
10. Neuroscience. Assessing nutritional imbalances. Available at: https:// www.neurorelief.com/index.php?option=com_content&task=view&id= 131&Itemid=48. Accessed November 24, 2010.
11. Kellermann G, Bull M, Ailts J, et al. Understanding diurnal variation. Technical Bulletin Issue 4. Osceola, WI: NeuroScience Inc; January 9, 2004. Available at: https://www.neurorelief.com/index. php?option=com_content&task=view&id=224&Itemid=48. Accessed November 24, 2010.
12. Marc D, Ailts J, Ailts-Campeau D, et al. Neurotransmitters excreted in the urine as biomarkers of nervous system activity: validity and clinical applicability. Neurosci Biobehav Rev. 2011;35:635-644.
13. Trachte G, Uncini T, Hinz M. Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population. Neuropsychiatr Dis Treat. 2009;5:227-235.
14. Hughes J, Watkins L, Blumenthal J, Kuhn C, Sherwood A. Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women. J Psychosom Res. 2004;57:353-358.